Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
May 31, 2026 30.11%
February 28, 2026 31.31%
November 30, 2025 29.75%
August 31, 2025 30.28%
May 31, 2025 30.24%
November 30, 2024
August 31, 2024 30.16%
May 31, 2024 30.32%
February 29, 2024 30.46%
November 30, 2023 30.75%
August 31, 2023 30.05%
May 31, 2023 30.44%
February 28, 2023 30.47%
November 30, 2022 30.28%
August 31, 2022 29.76%
May 31, 2022 29.53%
February 28, 2022 29.90%
November 30, 2021 29.84%
August 31, 2021 29.33%
May 31, 2021 29.18%
February 28, 2021 28.82%
November 30, 2020 29.08%
August 31, 2020 28.97%
May 31, 2020 29.50%
February 29, 2020 29.21%
Date Value
November 30, 2019 28.79%
August 31, 2019 28.65%
May 31, 2019 29.33%
February 28, 2019 28.50%
November 30, 2018 28.37%
August 31, 2018 28.19%
May 31, 2018 28.20%
February 28, 2018 28.71%
November 30, 2017 29.00%
August 31, 2017 28.74%
May 31, 2017 29.27%
February 28, 2017 29.13%
November 30, 2016 28.51%
August 31, 2016 27.80%
May 31, 2016 28.63%
February 29, 2016 28.30%
November 30, 2015 28.44%
August 31, 2015 27.87%
May 31, 2015 28.50%
February 28, 2015 28.30%
November 30, 2014 28.35%
August 31, 2014 27.81%
May 31, 2014 27.67%
February 28, 2014 28.54%
November 30, 2013 28.80%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sundrug Co., Ltd. 25.72%
Sugi Holdings Co., Ltd. 30.84%
COSMOS Pharmaceutical Corp. 20.66%
MatsukiyoCocokara & Co. 35.11%
Ain Holdings, Inc. 12.85%